Retrovirology (Sep 2012)

CD40L adjuvant for DNA/MVA vaccine: enhanced protection from acquisition of neutralization sensitive & neutralization resistant mucosal SIV infections

  • Kwa S,
  • Sadagopal S,
  • Hong J,
  • Gangadhara S,
  • Basu R,
  • Lai L,
  • Iyer S,
  • Araki K,
  • Earl PL,
  • Wyatt L,
  • Villinger F,
  • Moss B,
  • Ahmed R,
  • Amara RR

DOI
https://doi.org/10.1186/1742-4690-9-S2-P365
Journal volume & issue
Vol. 9, no. Suppl 2
p. P365

Abstract

Read online

No abstracts available.